Qsymia has become a second-line option, recommended when GLP-1 medications are not tolerated, not accessible, or contraindicated
Dry mouth alone does not indicate overdosing, but persistent symptoms during dose increases should prompt a medication review
In Study 1, we found that participants evaluated an individual who lost weight with a GLP-1 more harshly than an individual who lost weight via diet and exercise (i.e., higher in negative traits, lower in positive traits, more unhealthy, less willing to affiliate)
And if you did ask it to give you 975A, your run time would be very short, like 7.6Mins in this case. Very well said
Both forms contain the same active ingredient, semaglutide, and are effective for controlling hunger and supporting long-term weight loss